Impaired aerobic exercise capacity and cardiac autonomic control in primary antiphospholipid syndrome

Lupus

Volumn 22, Issue 9, 2013, Pages 928-931

  Garcia, C B ^a   Perandini, L A ^a   Seguro, L P C ^a   Gualano, B ^a   Roschel, H ^a   Bonfa, E ^a   Borba, E F ^a   Sa Pinto A L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

antiphospholipid syndrome; autonomic nervous systemic; Exercise; oxygen uptake

Indexed keywords

WARFARIN;

ADULT; AEROBIC CAPACITY; AEROBIC EXERCISE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BODY MASS; CHRONOTROPISM; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; EXHAUSTION; FEMALE; HEART RATE; HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; TREADMILL EXERCISE; ANAEROBIC THRESHOLD; AUTONOMIC NERVOUS SYSTEM; CASE CONTROL STUDY; EXERCISE TEST; EXERCISE TOLERANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; ANAEROBIC THRESHOLD; ANTIPHOSPHOLIPID SYNDROME; AUTONOMIC NERVOUS SYSTEM; CASE-CONTROL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMANS; OXYGEN CONSUMPTION; SEDENTARY LIFESTYLE; YOUNG ADULT;

EID: 84880859004     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313497415     Document Type: Article

References (27)

1. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010 ; 30: 1498-1509
2. Espinosa G, Cervera R. Antiphospholipid syndrome: Frequency, main causes and risk factors of mortality. Nat Rev Rheumatol. 2010 ; 6: 296-300
3. Sandvik L, Erikssen J, Ellestad M, et al. Heart rate increase and maximal heart rate during exercise as predictors of cardiovascular mortality: A 16-year follow-up study of 1960 healthy men. Coron Artery Dis. 1995 ; 6: 667-679
4. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999 ; 341: 1351-1357
5. Forte S, Carlone S, Vaccaro F, et al. Pulmonary gas exchange and exercise capacity in patients with systemic lupus erythematosus. J Rheumatol. 1999 ; 26: 2591-2594
6. do Prado DL, Gualano B, Miossi R, et al. Abnormal chronotropic reserve and heart rate recovery in patients with SLE: A case-control study. Lupus. 2011 ; 20: 717-720
7. da Cunha Ribeiro RP, Roschel H, Artioli GG, et al. Cardiac autonomic impairment and chronotropic incompetence in fibromyalgia. Arthritis Res Ther. 2011 ; 13: R190 - R190
8. Cimen B, Deviren SD, Yorgancloǧlu ZR. Pulmonary function tests, aerobic capacity, respiratory muscle strength and endurance of patients with rheumatoid arthritis. Clin Rheumatol. 2001 ; 20: 168-173
9. Janse van Rensburg DC, Ker JA, Grant CC, Fletcher L. Autonomic impairment in rheumatoid arthritis. Int J Rheum Dis. 2012 ; 15: 419-426
10. Carter R, Riantawan P, Banham SW, Sturrock RD. An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis. Respir Med. 1999 ; 93: 700-708
11. Kaya EB, Okutucu S, Aksoy H, et al. Evaluation of cardiac autonomic functions in patients with ankylosing spondylitis via heart rate recovery and heart rate variability. Clin Res Cardiol. 2010 ; 99: 803-808
12. Bilora F, Biasiolo M, Zancan A, et al. Autonomic dysfunction and primary antiphospholipid syndrome: A frequent and frightening correlation?. Int J Gen Med. 2012 ; 5: 339-343
13. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
14. Wasserman K, Whipp BJ, Koyl SN, Beaver WL. Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol. 1973 ; 35: 236-243
15. Brubaker PH, Kitzman DW. Chronotropic incompetence: Causes, consequences, and management. Circulation. 2011 ; 123: 1010-1020
16. Boström C, Dupré B, Tengvar P, Jansson E, Opava CH, Lundberg IE. Aerobic capacity correlates to self-assessed physical function but not to overall disease activity or organ damage in women with systemic lupus erythematosus with low-to-moderate disease activity and organ damage. Lupus. 2008 ; 17: 100-104
17. Blair SN, Kampert JB, Kohl HW, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA. 1996 ; 276: 205-210
18. Tsuji H, Larson MG, Venditti FJ, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996 ; 94: 2850-2855
19. Arena R, Arrowood JA, Fei D, Shelar S, Helm S, Kraft KA. The influence of sex on the relationship between heart rate recovery and other cardiovascular risk factors in apparently healthy subjects. Scand J Med Sci Sports. 2010 ; 20: 291-297
20. Oliveira NC, dos Santos Sabbag LM, de Sá Pinto AL, Borges CL, Lima FR. Aerobic exercise is safe and effective in systemic sclerosis. Int J Sports Med. 2009 ; 30: 728-732
21. Flachenecker P. Autoimmune diseases and rehabilitation. Autoimmun Rev. 2012 ; 11: 219-225
22. Perandini LA, de Sá-Pinto AL, Roschel H, et al. Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases. Autoimmun Rev. 2012 ; 12: 218-224
23. Miossi R, Benatti FB, de Sá Pinto A, et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: A randomized trial. Arthritis Care Res (Hoboken). 2012 ; 64: 1159-1166
24. Franklin BA, Billecke S. Putting the benefits and risks of aerobic exercise in perspective. Curr Sports Med Rep. 2012 ; 11: 201-208
25. Shibata Y, Hashimoto H, Kurata C, Ohno R, Kazui T, Takinami M. Influence of physical activity on warfarin therapy. Thromb Haemost. 1998 ; 80: 203-204
26. Hassett AL, Gevirtz RN. Nonpharmacologic treatment for fibromyalgia: Patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine. Rheum Dis Clin North Am. 2009 ; 35: 393-407
27. Hassett AL, Radvanski DC, Vaschillo EG, et al. A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia. Appl Psychophysiol Biofeedback. 2007 ; 32: 1-10